96 related articles for article (PubMed ID: 24251328)
41. Galactosyl prodrug of ketorolac: synthesis, stability, and pharmacological and pharmacokinetic evaluations.
Curcio A; Sasso O; Melisi D; Nieddu M; La Rana G; Russo R; Gavini E; Boatto G; Abignente E; Calignano A; Rimoli MG
J Med Chem; 2009 Jun; 52(12):3794-800. PubMed ID: 19459639
[TBL] [Abstract][Full Text] [Related]
42. An ex vivo investigation into the transurothelial permeability and bladder wall distribution of the nonsteroidal anti-inflammatory ketorolac.
Williams NA; Bowen JL; Al-Jayyoussi G; Gumbleton M; Allender CJ; Li J; Harrah T; Raja A; Joshi HB
Mol Pharm; 2014 Mar; 11(3):673-82. PubMed ID: 24460452
[TBL] [Abstract][Full Text] [Related]
43. Passive versus electrotransport-facilitated transdermal absorption of ketorolac.
Park K; Verotta D; Gupta SK; Sheiner LB
Clin Pharmacol Ther; 1998 Mar; 63(3):303-15. PubMed ID: 9542474
[TBL] [Abstract][Full Text] [Related]
44. Rapid pain relief using transdermal film forming polymeric solution of ketorolac.
Ammar HO; Ghorab M; Mahmoud AA; Makram TS; Ghoneim AM
Pharm Dev Technol; 2013; 18(5):1005-16. PubMed ID: 22191998
[TBL] [Abstract][Full Text] [Related]
45. Stereospecific pharmacokinetics of free and protein-bound ketoprofen in serum and synovial fluid of horses after intravenous and intramuscular administration.
Brink P; DeGraves F; Ravis WR; Johansen D; Campbell JD; Duran SH
Am J Vet Res; 1998 Jun; 59(6):739-43. PubMed ID: 9622744
[TBL] [Abstract][Full Text] [Related]
46. Intravenous prediction of human pharmacokinetic parameters for ketorolac, a non-steroidal anti-inflammatory agent, using allometry approach.
Gilibili RR; Mullangi R; Srinivas NR
Eur J Drug Metab Pharmacokinet; 2011 Jun; 36(2):87-93. PubMed ID: 21380569
[TBL] [Abstract][Full Text] [Related]
47. Determination of tegaserod by LC-ESI-MS/MS and its application to a pharmacokinetic study in healthy Chinese volunteers.
Zou JJ; Bian XJ; Ding L; Zhu YB; Fan HW; Xiao DW
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(1):151-7. PubMed ID: 18069077
[TBL] [Abstract][Full Text] [Related]
48. Population pharmacokinetics of ketorolac in neonates and young infants.
Zuppa AF; Mondick JT; Davis L; Cohen D
Am J Ther; 2009; 16(2):143-6. PubMed ID: 19300040
[TBL] [Abstract][Full Text] [Related]
49. Population pharmacokinetic analysis of Ibuprofen enantiomers in preterm newborn infants.
Gregoire N; Desfrere L; Roze JC; Kibleur Y; Koehne P
J Clin Pharmacol; 2008 Dec; 48(12):1460-8. PubMed ID: 18796580
[TBL] [Abstract][Full Text] [Related]
50. Postoperative ketorolac tromethamine use in infants aged 6-18 months: the effect on morphine usage, safety assessment, and stereo-specific pharmacokinetics.
Lynn AM; Bradford H; Kantor ED; Seng KY; Salinger DH; Chen J; Ellenbogen RG; Vicini P; Anderson GD
Anesth Analg; 2007 May; 104(5):1040-51, tables of contents. PubMed ID: 17456651
[TBL] [Abstract][Full Text] [Related]
51. Stereospecific analytical method development and preliminary in vivo pharmacokinetic characterization of pinostrobin in the rat.
Sayre CL; Zhang Y; Martinez SE; Takemoto JK; Davies NM
Biomed Chromatogr; 2013 May; 27(5):548-50. PubMed ID: 23070926
[TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetics of ketorolac pentyl ester, a novel ester derivative of ketorolac, in rabbits.
Tzeng JI; Su WL; Chu KS; Cheng KI; Chu CC; Shieh JP; Wang JJ
Kaohsiung J Med Sci; 2005 Aug; 21(8):365-70. PubMed ID: 16158879
[TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetics and safety of ketorolac following single intranasal and intramuscular administration in healthy volunteers.
McAleer SD; Majid O; Venables E; Polack T; Sheikh MS
J Clin Pharmacol; 2007 Jan; 47(1):13-8. PubMed ID: 17192497
[TBL] [Abstract][Full Text] [Related]
54. Chiral analytical method development and application to pre-clinical pharmacokinetics of pinocembrin.
Sayre CL; Takemoto JK; Martinez SE; Davies NM
Biomed Chromatogr; 2013 Jun; 27(6):681-4. PubMed ID: 23212747
[TBL] [Abstract][Full Text] [Related]
55. Influence of the route of administration on the pharmacokinetics of pirprofen enantiomers in the rat.
Brocks DR; Liang WT; Jamali F
Chirality; 1993; 5(2):61-4. PubMed ID: 8343343
[TBL] [Abstract][Full Text] [Related]
56. Chiral pharmacokinetics of ketorolac in sheep after intravenous and intramuscular administration of the racemate.
Santos Y; Ballesteros C; Ros JM; Lázaro R; Rodríguez C; Encinas T
J Vet Pharmacol Ther; 2001 Dec; 24(6):443-6. PubMed ID: 11903876
[No Abstract] [Full Text] [Related]
57. Enantioselective pharmacokinetics of racemic carprofen in New Zealand white rabbits.
Hawkins MG; Taylor IT; Craigmill AL; Tell LA
J Vet Pharmacol Ther; 2008 Oct; 31(5):423-30. PubMed ID: 19000261
[TBL] [Abstract][Full Text] [Related]
58. Permeability of pure enantiomers of ketorolac through human cadaver skin.
Roy SD; Chatterjee DJ; Manoukian E; Divor A
J Pharm Sci; 1995 Aug; 84(8):987-90. PubMed ID: 7500285
[TBL] [Abstract][Full Text] [Related]
59. Enantioselectivity in the steady-state pharmacokinetics of metoprolol in hypertensive patients.
Cerqueira PM; Cesarino EJ; Mateus FH; Mere Y; Santos SR; Lanchote VL
Chirality; 1999; 11(7):591-7. PubMed ID: 10423287
[TBL] [Abstract][Full Text] [Related]
60. The problem of racemization in the stereospecific assay and pharmacokinetic evaluation of ketorolac in human and rats.
Vakily M; Corrigan B; Jamali F
Pharm Res; 1995 Nov; 12(11):1652-7. PubMed ID: 8592665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
